Skip to main content

Why we need diversity, equity and inclusion (DEI) in clinical and public health research

Diversity, equity, and inclusion (DEI) are essential in clinical and public health research, ensuring discoveries and interventions benefit all sections of society; and enhancing the quality, relevance, and impact of research. Ensuring that diverse populations are represented appropriately within research is a scientific necessity. By embedding DEI principles into research design and execution, researchers can generate findings that are broadly applicable across the population while also addressing long-standing health disparities.

DEI is needed in clinical and public health research because it improves the generalisability and relevance of research findings. Research outcomes must apply to the diverse populations they are intended to serve. By including participants from different racial, ethnic, gender, socioeconomic, and geographic backgrounds, studies can avoid biases that result from the narrower recruitment into research studies we often saw in the past. Without such diversity, research findings may only reflect outcomes relevant to a narrow segment of the population. For example, earlier research on cardiovascular disease often excluded women, resulting in treatment guidelines that were less relevant for them. 

DEI also plays a critical role in addressing health disparities. Under-represented populations, such as racial minorities and low-income groups, often experience worse health outcomes due to a lack of targeted research addressing their specific needs. Inclusive research helps identify population-specific health risks, barriers to care, and differential outcomes; thereby guiding the development of interventions that reduce disparities. 

Building community trust and engagement is another important outcome of DEI in research. When communities see themselves represented, they are more likely to trust the research process and participate actively. Higher participation rates lead to better data quality and more robust findings. Additionally, community engagement allows for the co-creation of solutions that reflect the unique needs and values of different populations, making health interventions more effective and sustainable. This approach has been particularly valuable in addressing vaccine hesitancy, where working closely with underrepresented communities has improved vaccination uptake and trust in public health efforts.

DEI also ensures that research accounts for biological and social differences that influence health outcomes. Biological and genetic variations, as well as differences in environmental and social factors, can significantly impact the effectiveness of treatments and interventions. Research that includes diverse populations can identify and address these differences, leading to more personalised and effective healthcare solutions. 

Beyond the practical benefits, DEI in research is also an ethical imperative. Every individual in our society, regardless of their background, deserves to benefit from the advances in scientific knowledge and healthcare.  Excluding certain groups from research not only perpetuates health disparities but also reinforces systemic injustices.  

Achieving DEI in research is challenging.  It requires a concerted effort to address issues such as recruitment and retention of diverse participants, cultural sensitivity in research design, and the need for inclusive research teams. This is why research organisations such as the US National Institutes for Health (NIH) and the English National Institute for Health and Care Research (NIHR) have mandatory sections on DEI in their application forms. 

In conclusion, diversity, equity, and inclusion (DEI) are not merely buzzwords. DEI contributes to improving the overall quality and validity of research data. Diverse and inclusive studies are less prone to selection bias and provide more comprehensive data, resulting in stronger, more reliable conclusions. The representative datasets from these studies enable researchers to develop evidence-based practices that guide clinical and public health initiatives globally.


Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...